ID
14618
Description
Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00193193
Link
https://clinicaltrials.gov/show/NCT00193193
Keywords
Versions (1)
- 4/24/16 4/24/16 -
Uploaded on
April 24, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT00193193
Eligibility Prostate Cancer NCT00193193
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Exclusion criteria
Data type
boolean
Alias
- UMLS CUI [1]
- C0680251
Description
Age
Data type
boolean
Alias
- UMLS CUI [1]
- C0001779
Description
Cancer treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C0920425
Description
Heart disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0018799
Description
Inclusion and exclusion criteria
Data type
boolean
Alias
- UMLS CUI [1]
- C1512693
- UMLS CUI [2]
- C0680251
Similar models
Eligibility Prostate Cancer NCT00193193
- StudyEvent: Eligibility
C0279025 (UMLS CUI [1,2])
C1516986 (UMLS CUI [2])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0680251 (UMLS CUI [2])